Antabio's Series A Round

Antabio raised a round of funding on October 16, 2017.

Antabio is a biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.…

Articles about Antabio's Series A Round: